Protocol No.: Amorcyte Study-002; A Prospective Randomized Double Blinded Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients with Acute Myocardial Infarction

  • Fujise, Kenichi (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/24/12 → 12/31/16

Funding

  • Amorcyte, Inc: $36,281.00